FDA publishes complete response letter for Disc Medicine's (IRON) NDA for bitopertin; have completed review of this application, as amended, and have determined that we cannot approve this application in its present form
The FDA's decision to publish a complete response letter for Disc Medicine's NDA indicates significant regulatory hurdles, suggesting that the current formulation of bitopertin is not approvable as is.
Fed's Goolsbee (2027 voter) says we are still seeing pretty high services inflation; hopes we've seen peak impact of tariffs; the job market has been steady, only modest cooling
Senate Democrats demand answers from Treasury Secretary Bessent and Secretary of State Rubio on the US lifting spyware sanctions, according to a letter
FDA publishes complete response letter for Disc Medicine's (IRON) NDA for bitopertin; have completed review of this application, as amended, and have determined that we cannot approve this application in its present form
US nuclear regulator issues permit for X-energy high assay low enriched uranium fuel (Haleu) plant for planned high-tech reactors
Pennsylvania jury finds Johnson & Johnson (JNJ) liable for woman's ovarian cancer
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This could negatively impact Disc Medicine's stock performance and may reflect broader caution regarding new drug approvals, potentially affecting investor sentiment in the biotech sector. Investors should monitor for any subsequent announcements that could address the FDA's concerns.
Related headlines
- Auto industry group reportedly urges US lawmakers o pass comprehensive ban on Chinese vehicles before year-end, according to reports1 hour ago
- OpenAI says it has applied the mitigation and monitoring recovery1 hour ago
- User reports indicate possible problems with Amazon (AMZN) Web Services in the US, according to Down Detector1 hour ago
- Cloudflare (NET) reportedly facing issues on certain custom domains1 hour ago
- Cliffwater Private Credit fund sees 16% redemption requests1 hour ago
- Alphabet's Google (GOOGL) launches Weathernext 3 AI model1 hour ago
- SpaceXAI (SPCX) Grok is experiencing issues and Anthropic investigation Claude errors1 hour ago
- Quantinuum (QNT) signed a MOU with Saudi Aramco to explore quantum-computing solutions aimed at addressing energy-sector challenges2 hours ago
- US House GOP leaders are planning to announce the final two weeks of the pre-election session are canceled, reports Politico2 hours ago
- US EQUITY OPEN: Dovish Waller helps push indices higher although AVGO guidance underwhelms3 hours ago
- AbbVie (ABBV) announced positive topline results from the Phase 3 CERVINO study evaluating etentamig in patients with triple-class exposed RRMM; study met its dual primary endpoints3 hours ago
- Tyson Foods (TSN) cuts its FY26 revenue outlook to between +1.5-2% (prev. guided +2.5-3.5%), citing additional pressure in its beef segment in Q43 hours ago
- US Daily Equity Opening News - MSFT to report quarterly Azure sales; AVGO and HPE fall on outlooks; SNOW surges on earnings beat3 hours ago
- US BROKER MOVES: AVGO upgraded at Macquarie; MRNA downgraded at Rothschild Redburn4 hours ago
- Meta (META) has launched WhatsApp bill payments in India, which will integrate 22,722 billers4 hours ago
- Blackstone Private Credit Fund to cap redemptions at 5% again4 hours ago
- Nvidia (NVDA) confirms it is to acquire Hugging Face for USD 12.93bln; Hugging Face will remain an open platform4 hours ago
- GE Vernova (GEV) supplies 16 turbines for ESB's 96 MW Chleansaid wind farm in Scottish highlands5 hours ago
- Campbell's (CPB) Q4 2026 (USD): Adj. EPS 0.39 (exp. 0.40), revenue 2.14bln (exp. 2.15bln). Cuts quarterly dividend to accelerate debt reduction 5 hours ago
- Polestar (PSNY) Q2 2026 (USD): Revenue 727mln (exp. 865mln)5 hours ago
The whole workspace, free to try.
Try it free